Efficacy and Safety of Paliperidone Extended-Release Tablets: Results of a 6-Week, Randomized, Placebo-Controlled Study

This publication has 26 references indexed in Scilit:

• Paliperidone Extended-Release Tablets for Prevention of Symptom Recurrence in Patients With Schizophrenia
  Journal of Clinical Psychopharmacology, 2007
• Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form
  Current Medical Research and Opinion, 2006
• Defining and Measuring Clinical Effectiveness in the Treatment of Schizophrenia
  Psychiatric Services, 2005
• Consensus Statement: Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
  The Journal of Clinical Psychiatry, 2004
• Evaluation of Drug-Induced QT Interval Prolongation
  Drug Safety, 2001
• Olanzapine
  Drugs, 2001
• Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social funtioning
  Acta Psychiatrica Scandinavica, 2000
• Schizophrenia: Do we really need placebo-controlled studies?
  European Neuropsychopharmacology, 1998
• Long-term treatment of chronic schizophrenia with risperidone
  International Clinical Psychopharmacology, 1998
• Efficacy and safety of risperidone in the long-term treatment of patients with schizophrenia
  Clinical Therapeutics, 1995